109 related articles for article (PubMed ID: 17974996)
1. Activation of Toll-like receptor 4 on tumor cells in vitro inhibits subsequent tumor growth in vivo.
Andreani V; Gatti G; Simonella L; Rivero V; Maccioni M
Cancer Res; 2007 Nov; 67(21):10519-27. PubMed ID: 17974996
[TBL] [Abstract][Full Text] [Related]
2. IFNβ produced by TLR4-activated tumor cells is involved in improving the antitumoral immune response.
Núñez NG; Andreani V; Crespo MI; Nocera DA; Breser ML; Morón G; Dejager L; Libert C; Rivero V; Maccioni M
Cancer Res; 2012 Feb; 72(3):592-603. PubMed ID: 22139376
[TBL] [Abstract][Full Text] [Related]
3. Expression of Toll-like receptor 4 in the prostate gland and its association with the severity of prostate cancer.
Gatti G; Quintar AA; Andreani V; Nicola JP; Maldonado CA; Masini-Repiso AM; Rivero VE; Maccioni M
Prostate; 2009 Sep; 69(13):1387-97. PubMed ID: 19496069
[TBL] [Abstract][Full Text] [Related]
4. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
[TBL] [Abstract][Full Text] [Related]
5. Essential role of Toll-like receptors for dendritic cell and NK1.1(+) cell-dependent activation of type 1 immunity by Lactobacillus pentosus strain S-PT84.
Koizumi S; Wakita D; Sato T; Mitamura R; Izumo T; Shibata H; Kiso Y; Chamoto K; Togashi Y; Kitamura H; Nishimura T
Immunol Lett; 2008 Oct; 120(1-2):14-9. PubMed ID: 18620001
[TBL] [Abstract][Full Text] [Related]
6. Lipid rafts regulate ethanol-induced activation of TLR4 signaling in murine macrophages.
Fernandez-Lizarbe S; Pascual M; Gascon MS; Blanco A; Guerri C
Mol Immunol; 2008 Apr; 45(7):2007-16. PubMed ID: 18061674
[TBL] [Abstract][Full Text] [Related]
7. Angelan isolated from Angelica gigas Nakai induces dendritic cell maturation through toll-like receptor 4.
Kim JY; Yoon YD; Ahn JM; Kang JS; Park SK; Lee K; Song KB; Kim HM; Han SB
Int Immunopharmacol; 2007 Jan; 7(1):78-87. PubMed ID: 17161820
[TBL] [Abstract][Full Text] [Related]
8. Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway.
Peng G; Wang HY; Peng W; Kiniwa Y; Seo KH; Wang RF
Immunity; 2007 Aug; 27(2):334-48. PubMed ID: 17656116
[TBL] [Abstract][Full Text] [Related]
9. A novel immunomodulatory protein from Poria cocos induces Toll-like receptor 4-dependent activation within mouse peritoneal macrophages.
Chang HH; Yeh CH; Sheu F
J Agric Food Chem; 2009 Jul; 57(14):6129-39. PubMed ID: 19548679
[TBL] [Abstract][Full Text] [Related]
10. TLR4 signaling in cancer cells promotes chemoattraction of immature dendritic cells via autocrine CCL20.
Wang L; Liu Q; Sun Q; Zhang C; Chen T; Cao X
Biochem Biophys Res Commun; 2008 Feb; 366(3):852-6. PubMed ID: 18083111
[TBL] [Abstract][Full Text] [Related]
11. Activation of toll-like receptor 4 (TLR4) by in vivo and in vitro exposure of rat epididymis to lipopolysaccharide from Escherichia Coli.
Rodrigues A; Queiróz DB; Honda L; Silva EJ; Hall SH; Avellar MC
Biol Reprod; 2008 Dec; 79(6):1135-47. PubMed ID: 18703421
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 4 mediates an antitumor host response induced by Salmonella choleraesuis.
Lee CH; Wu CL; Shiau AL
Clin Cancer Res; 2008 Mar; 14(6):1905-12. PubMed ID: 18347194
[TBL] [Abstract][Full Text] [Related]
13. Partial role of TLR4 as a receptor responding to damage-associated molecular pattern.
Lee KM; Seong SY
Immunol Lett; 2009 Jun; 125(1):31-9. PubMed ID: 19501120
[TBL] [Abstract][Full Text] [Related]
14. BRD-glucan exhibits potent immunochemotherapeutic activity in vitro and in vivo.
Moon SH; Heo JC; Fine RL; Kim HM; Kim SU; Yoon BD; Lee SH
Int J Oncol; 2005 Feb; 26(2):395-404. PubMed ID: 15645124
[TBL] [Abstract][Full Text] [Related]
15. Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation.
Li B; Zhang R; Li J; Zhang L; Ding G; Luo P; He S; Dong Y; Jiang W; Lu Y; Cao H; Zheng J; Zhou H
Int Immunopharmacol; 2008 Mar; 8(3):379-89. PubMed ID: 18279792
[TBL] [Abstract][Full Text] [Related]
16. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.
Nonaka K; Saio M; Suwa T; Frey AB; Umemura N; Imai H; Ouyang GF; Osada S; Balazs M; Adany R; Kawaguchi Y; Yoshida K; Takami T
J Leukoc Biol; 2008 Sep; 84(3):679-88. PubMed ID: 18566103
[TBL] [Abstract][Full Text] [Related]
17. Statins inhibit toll-like receptor 4-mediated lipopolysaccharide signaling and cytokine expression.
Hodgkinson CP; Ye S
Pharmacogenet Genomics; 2008 Sep; 18(9):803-13. PubMed ID: 18698233
[TBL] [Abstract][Full Text] [Related]
18. IFN-producing killer dendritic cells contribute to the inhibitory effect of poly I:C on the progression of murine melanoma.
Jiang Q; Wei H; Tian Z
J Immunother; 2008; 31(6):555-62. PubMed ID: 18528299
[TBL] [Abstract][Full Text] [Related]
19. Bacterial lipopolysaccharide induces increased expression of toll-like receptor (TLR) 4 and downstream TLR signaling molecules in bovine mammary epithelial cells.
Ibeagha-Awemu EM; Lee JW; Ibeagha AE; Bannerman DD; Paape MJ; Zhao X
Vet Res; 2008; 39(2):11. PubMed ID: 18096120
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effect of OK-432-derived DNA: one of the active constituents of OK-432, a streptococcal immunotherapeutic agent.
Oshikawa T; Okamoto M; Tano T; Sasai A; Kan S; Moriya Y; Ryoma Y; Saito M; Akira S; Sato M
J Immunother; 2006; 29(2):143-50. PubMed ID: 16531815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
